top of page

Search


Systemic Gaps Hinder Cell and Gene Therapy Adoption and Access
espite the transformative potential of cell and gene therapies, widespread adoption remains limited due to systemic gaps in infrastructure, reimbursement models, and coordination of care.
3 days ago


Cardinal Health: 2025 Advanced Therapies Report
In this report, you’ll learn from experts commenting on key challenges and emerging solutions within this space, including how cell gene therapies are revolutionizing patient care while creating new challenges for us as an industry.
6 days ago


Specialty Drugs Dominate Pharmaceutical Frontier in 2025
In a Q&A with Jeff Casberg, MS, RPh, senior vice president of clinical pharmacy services at IPD Analytics, Casberg explains the evolution of specialty drugs, the future of GLP-1 competition and what to expect from the traditional drug pipeline.
Apr 15


US Pharmaceutical Pipeline Expands With Innovation and Competition
A surge of generics, biosimilars, and innovative therapies are expected in 2025, addressing conditions from cancer to chronic diseases.
Apr 8


Nonopioid Pain Drug Journavx Gaining Traction With High Potential
Journavx is seeing strong initial market adoption, with growing payer coverage and ongoing clinical studies aimed at expanding its use
Mar 25
bottom of page